Talk:Radium-223

From WikiProjectMed
Jump to navigation Jump to search

Tradename

Xofigo is the tradename of the product, the product is still called alpharadin or Radium-223 chloride. Please adjust the page similar to other medicine products (enzalutamide instead of Xtandi etc.) — Preceding unsigned comment added by 150.148.14.8 (talk) 17:37, 25 June 2013 (UTC)[reply]

Yes, the article should not use a trade name as the title. I have now moved this page to Radium-223 chloride. -- Ed (Edgar181) 17:52, 25 June 2013 (UTC)[reply]

Along the same line, it seems to me that even "Radium-223 chloride" or "Radium-223 dichloride" (as the generic name given on the FDA datasheet seems to be) is slanted toward the particular manufactur's product. The standard chemical name for the active component is simply Radium-223. I therefore propose to Move (ie rename) this article to Radium-223 (radiopharmaceutical). Then, if some other manufacturer makes a pharmacologically equivalent preparation, such as radium-223 bromide, it could be discussed in the same article.CharlesHBennett (talk) 01:37, 7 December 2013 (UTC)[reply]

On further thought, I think it should be moved simply to Radium-223, with a short introduction (which I am writing) on the isotope's preparation, decay path, etc. This parallels the style of articles on other radioisotopes whose principal uses are medical, such as Strontium-89 and Technetium-99m, and would make it easy to incorporate into the comprehensive table of such isotopes in radiopharmacology. (There is no article on Radium-223 yet; Radium-223 points only to a general article on radium isotopes.) CharlesHBennett (talk) 10:59, 7 December 2013 (UTC)[reply]

Requested move 19 April 2015

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review. No further edits should be made to this section.

The result of the move request was: MOVE, there is clear consensus--Ymblanter (talk) 14:19, 4 May 2015 (UTC) Ymblanter (talk) 14:19, 4 May 2015 (UTC)[reply]



Radium-223-ChlorideRadium-223 – because the article is about the isotope, not just the drug. See discussion above. CharlesHBennett (talk) 04:02, 19 April 2015 (UTC)[reply]

  • I've made the above changes. YBG (talk) 05:43, 23 April 2015 (UTC)[reply]
  • agree per above--Ozzie10aaaa (talk) 12:37, 19 April 2015 (UTC)[reply]
  • Support per YBG. Double sharp (talk) 14:39, 19 April 2015 (UTC)[reply]
  • Support move (the isotope is the actual active ingredient unless there are cited refs that the chloride is biochemically relevant or that this compound is notable in any other way), and with YBG's editorial plans. According to history, the article was originally named for the drug and then was moved to the isotope name in the timeframe of the above discussion and with WP:ES explaining some basis. Then User:A8v moved it back a year later without explanation. DMacks (talk) 04:58, 23 April 2015 (UTC)[reply]

The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.

CharlesHBennett (talk) 11:11, 3 May 2015 (UTC)[reply]


The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.

New data

Beyer Pharma have updated thier numerical values for radioactive content and dose, from 1000kBq/ml to 1100 kBq/ml and to 55kBq/kg for dose. This was communicated in the document "Direct to Healthcare Professional Communication Letter agreed by the CHMP on 22nd October 2015", dated 9th Feb 2016. — Preceding unsigned comment added by 188.39.68.2 (talk) 13:16, 19 July 2016 (UTC)[reply]